Alpha Teknova, Inc.
NASDAQ:TKNODrug Manufacturers - Specialty & Generic
+$0.23 today
- Market cap
- $495.68M
- Beta
- 0.63
- P/E (TTM)
- -16.2
- EPS (TTM)
- -$0.32
Volume 0.30M
Average 0.13M
TKNO Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Alpha Teknova, Inc.NASDAQ: TKNO
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $221K (cash outflow) rose 7.3% year over year, ahead of the -4.6% change in trailing-twelve-month capital expenditures. Sequentially, it fell 36.5% from the prior quarter. Over 3 fiscal years it compounded at -65.6% a year.
Context
- Capital expenditures amounted to 2.8% of revenue in FY2025, down 0.1 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +7.3% holds above the trailing-twelve-month pace of -4.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (1.15M) USD
- Year-over-year change
- -2.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.15M) | -2.0% |
| FY2024 | 2024-12-31 | (1.13M) | +85.8% |
| FY2023 | 2023-12-31 | (7.93M) | +71.8% |
| FY2022 | 2022-12-31 | (28.15M) | -41.6% |
| FY2021 | 2021-12-31 | (19.88M) | — |
Capital Expenditures vs competitors
How TKNO compares with its peers on the latest reported figures
- TKNO's LTM Mar 2026 capital expenditures of $1.16M is the 7th largest of the 8 companies compared; the peer median is $19.69M.
- Its year-over-year change of -4.6% is the 4th highest of 8, against a peer median of -7.9%.
- Capital expenditures amounts to 2.8% of revenue for TKNO, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $30.08M | -11.2% | -8.6% | 4.8% | |
| LTM Sep 2026 | $29.4M | +8.1% | -9.0% | 2.4% | |
| LTM Jun 2026 | $24.09M | -7.9% | -43.9% | 3.1% | |
| LTM Mar 2026 | $19.69M | +488.5% | -3.0% | 19.7% | |
| LTM Jun 2026 | $9.85M | -58.2% | -8.4% | 4.7% | |
| LTM Mar 2026 | $3.82M | -69.8% | +29.5% | 4.4% | |
| LTM Mar 2026 | $1.16M | -4.6% | -65.6% | 2.8% | |
| LTM Mar 2026 | $0 | +100.0% | -10.6% | 0.0% | |
| Peer median (excluding TKNO) | $19.69M | -7.9% | -8.6% | 4.4% | |
Competitors are the stored peer set for TKNO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.8M) | (47.47M) | (36.78M) | (26.75M) | (17.26M) |
| Depreciation & Amortization | 2.88M | 3.17M | 5.66M | 6.58M | 6.34M |
| Deferred Income Tax | (2.84M) | (1.93M) | (304K) | (92K) | 52K |
| Stock-Based Compensation | 1.55M | 3.71M | 4.14M | 3.67M | 3.43M |
| Change in Working Capital | (1.77M) | (7.33M) | 2.25M | (873K) | (2.68M) |
| Accounts Receivables | (49K) | 380K | 314K | (494K) | (374K) |
| Inventory | (2.25M) | (7.55M) | 330K | 244K | (2.37M) |
| Accounts Payables | 270K | 572K | (773K) | (594K) | 470K |
| Other Working Capital | 263K | (736K) | 2.38M | (29K) | (407K) |
| Other Non-Cash Items | 906K | 22.46M | 6.22M | 5.08M | 1.47M |
| Operating Cash Flow | (9.07M) | (27.4M) | (18.81M) | (12.39M) | (8.65M) |
| Capital Expenditures | (19.88M) | (28.15M) | (7.93M) | (1.13M) | (1.15M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (30.28M) | (17.15M) |
| Sales of Investments | 1.83M | 0 | 0 | 4M | 29M |
| Other Investing Activities | 529K | 0 | 197K | 125K | 0 |
| Investing Cash Flow | (17.52M) | (28.15M) | (7.74M) | (27.28M) | 10.7M |
| Debt Repayment | 11.89M | 10.14M | (10M) | 0 | 1.11M |
| Common Stock Issued | 102.67M | 439K | 22.5M | 15.1M | 211K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (3.77M) | (307K) | (32K) | (214K) | (1.17M) |
| Financing Cash Flow | 110.79M | 10.27M | 12.8M | 14.89M | 151K |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 84.2M | (45.28M) | (13.75M) | (24.78M) | 2.2M |
| Free Cash Flow | (28.95M) | (55.55M) | (26.75M) | (13.52M) | (9.79M) |
Alpha Teknova, Inc.
NASDAQ:TKNO
Intrinsic Alpha fair value
Locked
Current Price
$7.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.